Prognostic Factors for Uterine Sarcoma and Carcinosarcoma: Insights from a 10-Year Follow-Up Study

Beata Kotowicz; Anna Dańska-Bidzińska; Małgorzata Fuksiewicz; Anna Nasierowska-Guttmejer; Dorota Raczkiewicz; Mariusz Gujski; Szymon Piątek; Mariusz Bidziński

doi:10.12659/MSM.941562

07 December 2023: Clinical Research

Prognostic Factors for Uterine Sarcoma and Carcinosarcoma: Insights from a 10-Year Follow-Up Study

Beata Kotowicz ^1ACDEF* , Anna Dańska-Bidzińska ^2ABDEG , Małgorzata Fuksiewicz ^1BCDE , Anna Nasierowska-Guttmejer ^3BC , Dorota Raczkiewicz ^4C , Mariusz Gujski ^5BEF , Szymon Piątek ^6B , Mariusz Bidziński ^6AEG

DOI: 10.12659/MSM.941562

Med Sci Monit 2023; 29:e941562

Authors information Article notes Copyright and License information

Background Material and Methods Results Discussion Conclusions References

View HTML version

Figure 3 Overall survival according to histopathological types of sarcoma. Created using Statistica 13.1 software (STATSOFT; Statistica, Tulsa, OK, USA), Kaplan-Meier survival analysis.

Back to the Article

Prognostic Factors for Uterine Sarcoma and Carcinosarcoma: Insights from a 10-Year Follow-Up Study

Your Privacy